Khan Arshan, Nashed Bola, Issa Mohamed, Khan Muhammad Zatmar
Internal Medicine, Ascension St. John Hospital, Detroit, USA.
Internal Medicine, Ascension St. John hospital, Detroit, USA.
Cureus. 2022 Feb 9;14(2):e22050. doi: 10.7759/cureus.22050. eCollection 2022 Feb.
Sickle cell intrahepatic cholestasis (SCIC) is a rare but potentially fatal complication of sickle cell disease (SCD), with high mortality, observed mainly in patients with homozygous sickle cell anemia. Herein, we have reported a case of severe SCIC with a poor outcome despite aggressive measures including exchange transfusion and use of vasopressors. The patient was admitted with generalized weakness, confusion, rigors, chills, and signs of hepatic failure, such as hyperbilirubinemia, hypoalbuminemia, and coagulopathy. There was no evidence of viral hepatitis or biliary obstruction. The patient received two exchange transfusions, but he continued to deteriorate clinically despite exchange transfusion and developed hemorrhagic shock and multiorgan failure. The patient was made comfort care as per family wishes. This case emphasizes the importance of early diagnosis of sickle cell intrahepatic cholestasis and poor prognosis despite aggressive measures.
镰状细胞性肝内胆汁淤积症(SCIC)是镰状细胞病(SCD)一种罕见但可能致命的并发症,死亡率高,主要见于纯合子镰状细胞贫血患者。在此,我们报告了一例严重的SCIC病例,尽管采取了包括换血输血和使用血管加压药在内的积极措施,但预后仍很差。该患者因全身无力、意识模糊、寒战、发冷以及肝功能衰竭迹象(如高胆红素血症、低白蛋白血症和凝血障碍)入院。没有病毒性肝炎或胆道梗阻的证据。患者接受了两次换血输血,但尽管进行了换血输血,他的临床状况仍持续恶化,并发了失血性休克和多器官功能衰竭。根据家属意愿,对患者进行了舒适护理。该病例强调了早期诊断镰状细胞性肝内胆汁淤积症的重要性,以及尽管采取积极措施但预后仍不佳的情况。